Selective modulation of the human platelet thromboxane A2/prostaglandin H2 receptor by eicosapentaenoic and docosahexaenoic acids in intact platelets and solubilized platelet membranes.
Open Access
- 1 April 1992
- journal article
- abstracts
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 267 (10) , 6541-6547
- https://doi.org/10.1016/s0021-9258(19)50461-6
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Platelet desensitization by arachidonic acid is associated with the suppression of endoperoxide/thromboxane A2 binding to the membrane receptorBiochimica et Biophysica Acta (BBA) - General Subjects, 1989
- Cardiovascular Effects of n-3 Fatty AcidsNew England Journal of Medicine, 1988
- Interference of eicosapentaenoic and docosahexaenoic acids with arachidonate- and U46619-induced platelet activation and desensitizationBiochemical Pharmacology, 1988
- Prophylaxis of Atherosclerosis with Marine Omega-3 Fatty AcidsAnnals of Internal Medicine, 1987
- Inhibition of platelet aggregation by unsaturated fatty acids through interference with a thromboxane-mediated processBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1987
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986
- Inhibition of human platelet phospholipase A2 activity by unsaturated fatty acids.Proceedings of the National Academy of Sciences, 1985
- Inhibition of platelet function by cis-unsaturated fatty acidsBlood, 1984
- Inhibition of platelet phospholipase-A2 as a mechanism for the anti-aggregating effect of linoleic acidInflammation Research, 1980
- Effects of all CIS-5, 8,11,14,17 eicosapentaenoic acid and PGH3 on platelet aggregationProstaglandins, 1979